[1]
“New multiple therapy of resistant and relapsing dermatophyte infections during epidemic status”, J Pak Assoc Dermatol, vol. 32, no. 3, pp. 464–471, Aug. 2022, doi: 10.66344/jpad.v32i3.1994.